Related Experiment Video

Updated: Mar 8, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.5K

Antitumoral Activity Of Nitric Oxide-Releasing Compounds

Magdalena Klink1, Michal Kielbik1, Izabela Szulc Kielbik1

  • 1Institute of Medical Biology, Polish Academy of Sciences, Lodz, Poland.

Redox Biology
|February 7, 2017
PubMed
Abstract

Insights

Nitric oxide (NO) donors effectively inhibited ovarian cancer cell growth and increased sensitivity to cisplatin. These compounds also induced apoptosis and reduced key signaling proteins and pro-metastatic factors, showing potential as supportive cancer therapies.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Ovarian cancer treatment faces challenges due to drug resistance.
  • Novel therapeutic strategies are crucial for overcoming treatment resistance.
  • Nitric oxide (NO) donors are promising agents for cancer therapy.

Purpose of the Study:

  • To evaluate the anti-cancer effects of NO donors on ovarian cancer cell lines.
  • To assess the impact of NO donors on cancer cell proliferation, signaling pathways, and metastatic potential.
  • To determine the synergistic effect of NO donors with cisplatin.

Main Methods:

  • SK-OV-3 and OVCAR-3 ovarian cancer cell lines were treated with SPER/NO and DETA/NO.
  • Cytotoxicity, apoptosis, and signaling protein phosphorylation (STAT-3, AKT) were assessed.
  • Expression of VEGF-A, MMPs, and TGF-β was evaluated.

Main Results:

  • NO donors inhibited ovarian cancer cell proliferation and enhanced cisplatin sensitivity.
  • Apoptosis was induced, and STAT-3 and AKT signaling pathways were downregulated.
  • Secretion of pro-metastatic factors (VEGF-A, MMPs, TGF-β) was reduced.

Conclusions:

  • NO donors exhibit broad-spectrum activity against ovarian cancer cells.
  • SPERO/NO and DETA/NO show significant potential as adjunct therapies in ovarian cancer treatment.

More Related Videos

Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds08:23

Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds

Published on: February 16, 2022

4.9K
Analytical Techniques for Assaying Nitric Oxide Bioactivity11:28

Analytical Techniques for Assaying Nitric Oxide Bioactivity

Published on: June 18, 2012

18.6K

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.5K
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.4K
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.3K